Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.0070
0.00 (0.00%)
Jun 20, 2024, 12:00 AM EDT - Market closed

Baudax Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20222021202020192018 2017
Cash & Equivalents
5.2615.8930.3417.740
Upgrade
Cash & Cash Equivalents
5.2615.8930.3417.740
Upgrade
Cash Growth
-66.91%-47.63%71.04%--
Upgrade
Receivables
00.540.0500
Upgrade
Inventory
052.9800
Upgrade
Other Current Assets
1.092.063.352.42.51
Upgrade
Total Current Assets
6.3523.4936.7220.142.51
Upgrade
Property, Plant & Equipment
0.865.025.055.553.98
Upgrade
Goodwill and Intangibles
2.1323.8126.3828.5328.53
Upgrade
Other Long-Term Assets
0.70.960.5800
Upgrade
Total Long-Term Assets
3.6929.7832.0234.0832.51
Upgrade
Total Assets
10.0353.2868.7354.2135.02
Upgrade
Accounts Payable
3.21.473.650.272.65
Upgrade
Current Debt
5.832.220.680.320
Upgrade
Other Current Liabilities
12.4311.9613.797.1220.13
Upgrade
Total Current Liabilities
21.4615.6518.137.7122.78
Upgrade
Long-Term Debt
2.16.318.470.460
Upgrade
Other Long-Term Liabilities
10.7118.156.9362.7780.59
Upgrade
Total Long-Term Liabilities
12.8124.4165.463.2280.59
Upgrade
Total Liabilities
34.2740.0583.5370.93103.37
Upgrade
Total Debt
7.948.539.150.770
Upgrade
Debt Growth
-6.99%-6.79%1083.96%--
Upgrade
Retained Earnings
-190.9-132.09-112.32-36.220
Upgrade
Shareholders' Equity
-24.2413.23-14.8-16.72-68.35
Upgrade
Net Cash / Debt
-2.687.3621.1916.970
Upgrade
Net Cash / Debt Growth
--65.27%24.89%--
Upgrade
Net Cash Per Share
-8.07134.461591.322540.35-
Upgrade
Working Capital
-15.117.8518.5912.42-20.27
Upgrade
Book Value Per Share
-73.10241.62-1111.37-2503.49-10233.01
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).